A Clinical Trial to Evaluate Safety of Gusacitinib in Patients With Systemic Lupus Erythematosus (SLE) or Lupus

NCT06238531 · clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
NIH
Sponsor class

Stopped Drug company discontinuing study.

Conditions

Interventions

Sponsor

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)